Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Schilke Tobin received 471 Crinetics Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Aug 20, 2026 · Filed Aug 24, 2026
On Aug 20, 2026, Schilke Tobin (Chief Financial & Infra. Ofcr.) received 471 Crinetics Pharmaceuticals, Inc. shares as an award, leaving 79,427 shares. Filed Aug 24, 2026 (Form 4).
- Awarded
- 471 shares
- Holding after
- 79,427 shares
- Trading plan
- No
- Role
- Chief Financial & Infra. Ofcr.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | Award | 471 | 79,427 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Schilke Tobin
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Schilke Tobin · Sep 1, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026